Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Helio Genomics Partners with Quest Diagnostics to Boost Accessibility of Liver Cancer Detection Test Helio Genomics has partnered with Quest Diagnostics to make its HelioLiver™ test widely accessible for early liver cancer detection through Quest's extensive network.

Helio Genomics Partners with Quest Diagnostics to Boost Accessibility of Liver Cancer Detection Test #United_States #Irvine #Quest_Diagnostics #cancer_detection #HelioLiver

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Timothy Wentworth Appointed to Quest Diagnostics Board of Directors, Strengthening Leadership Team Timothy Wentworth, a seasoned executive with extensive leadership experience in healthcare, has been elected to the board of Quest Diagnostics, enhancing their strategic direction.

Timothy Wentworth Appointed to Quest Diagnostics Board of Directors, Strengthening Leadership Team #Quest_Diagnostics #Secaucus #Walgreens_Boots #Timothy_Wentworth

Thiard News@F4F

@newsen.bsky.social

1 month ago

Quest Diagnostics Unveils AI Companion for Enhanced Lab Test Insights and Patient Empowerment Quest Diagnostics has launched the AI Companion, an innovative chat feature that interprets lab test results to enhance patient understanding and engagement.

Quest Diagnostics Unveils AI Companion for Enhanced Lab Test Insights and Patient Empowerment #USA #Quest_Diagnostics #Secaucus #AI_Companion #Lab_Tests

Thiard News@F4F

@newsen.bsky.social

1 month ago

Quest Diagnostics Appoints Benjamin Beauvalot as New Chief Strategy and M&A Officer Quest Diagnostics has announced the appointment of Benjamin Beauvalot as Senior Vice President and Chief Strategy and M&A Officer, aiming to enhance growth.

Quest Diagnostics Appoints Benjamin Beauvalot as New Chief Strategy and M&A Officer #United_States #Quest_Diagnostics #Secaucus #M&A_Leadership #Benjamin_Beauvalot

Thiard News@F4F

@newsen.bsky.social

1 month ago

Quest Diagnostics Set to Present Strategies at 2026 Healthcare Conference in Miami Quest Diagnostics will feature Sam Samad at the global healthcare conference. The event will showcase company strategies and insights into industry dynamics.

Quest Diagnostics Set to Present Strategies at 2026 Healthcare Conference in Miami #United_States #Miami #Healthcare_Conference #Quest_Diagnostics #Sam_Samad

Thiard News@F4F

@newsen.bsky.social

2 months ago

Quest Diagnostics Announces Impressive Fourth Quarter and Full Year 2025 Financial Results Quest Diagnostics released its financial performance for Q4 and full year 2025, highlighting significant revenue growth and anticipated earnings for 2026.

Quest Diagnostics Announces Impressive Fourth Quarter and Full Year 2025 Financial Results #USA #financial_results #revenue_growth #Quest_Diagnostics #Secaucus

Thiard News@F4F

@newsen.bsky.social

2 months ago

Quest Diagnostics Marks a Milestone with 15 Years of Increased Dividends and a Significant Share Buyback Plan Quest Diagnostics announces a 7.5% dividend increase and $1 billion share buyback, marking 15 years of consistent dividend growth.

Quest Diagnostics Marks a Milestone with 15 Years of Increased Dividends and a Significant Share Buyback Plan #United_States #share_buyback #dividend_increase #Quest_Diagnostics #Secaucus

Thiard News@F4F

@newsen.bsky.social

2 months ago

Quest Diagnostics Introduces Innovative Blood Test for Myeloma Patients Using Advanced Flow Cytometry Technology Quest Diagnostics has launched a revolutionary blood test utilizing advanced flow cytometry to detect residual disease in myeloma patients, offering high sensitivity and cost-effectiveness.

Quest Diagnostics Introduces Innovative Blood Test for Myeloma Patients Using Advanced Flow Cytometry Technology #United_States #Flow_Cytometry #Quest_Diagnostics #Secaucus,_NJ #Myeloma

Thiard News@F4F

@newsen.bsky.social

2 months ago

Quest Diagnostics Achieves Fortune's Most Admired Companies Recognition for 12th Year in a Row Quest Diagnostics has made it to Fortune's list of the World's Most Admired Companies for twelve consecutive years, highlighting its commitment to healthcare excellence.

Quest Diagnostics Achieves Fortune's Most Admired Companies Recognition for 12th Year in a Row #USA #healthcare #Quest_Diagnostics #Secaucus #DGX

Thiard News@F4F

@newsen.bsky.social

3 months ago

Quest Diagnostics to Showcase Cutting-Edge Data on ctDNA MRD Testing at ASCO 2026 Quest Diagnostics will unveil significant new data regarding circulating tumor DNA MRD testing at the 2026 ASCO Gastrointestinal Cancers Symposium in San Francisco.

Quest Diagnostics to Showcase Cutting-Edge Data on ctDNA MRD Testing at ASCO 2026 #United_States #San_Francisco #Quest_Diagnostics #Haystack_MRD #ASCO_Symposium

Thiard News@F4F

@newsen.bsky.social

3 months ago

Corewell Health Forms Joint Venture with Quest Diagnostics to Enhance Lab Services in Michigan Corewell Health and Quest Diagnostics have finalized a joint venture to enhance laboratory services in Michigan, aiming for improved access and quality of care for patients.

Corewell Health Forms Joint Venture with Quest Diagnostics to Enhance Lab Services in Michigan #United_States #Southfield #Quest_Diagnostics #Corewell_Health #Diagnostic_Lab

Thiard News@F4F

@newsen.bsky.social

3 months ago

Quest Diagnostics to Present at 44th Annual J.P. Morgan Healthcare Conference in 2026 Quest Diagnostics will present insights on healthcare strategies and market trends at the J.P. Morgan Healthcare Conference on January 12, 2026.

Quest Diagnostics to Present at 44th Annual J.P. Morgan Healthcare Conference in 2026 #United_States #San_Francisco #Healthcare_Conference #Quest_Diagnostics #Jim_Davis

Thiard News@F4F

@newsen.bsky.social

5 months ago

Quest Diagnostics Announces Quarterly Cash Dividend for Shareholders Quest Diagnostics has declared a quarterly cash dividend of $0.80 per share, signaling continued financial strength for its shareholders as of January 2026.

Quest Diagnostics Announces Quarterly Cash Dividend for Shareholders #USA #Cash_Dividend #Quest_Diagnostics #Secaucus #Diagnostic_Services

Thiard News@F4F

@newsen.bsky.social

5 months ago

Quest Diagnostics Executive to Discuss Innovations at Citi's 2025 Global Healthcare Conference At the upcoming Citi's 2025 Global Healthcare Conference, Quest Diagnostics' CFO Sam Samad will reveal insights on the latest strategies, performance metrics, and market trends.

Quest Diagnostics Executive to Discuss Innovations at Citi's 2025 Global Healthcare Conference #United_States #Miami #Quest_Diagnostics #Global_Healthcare #Sam_Samad

Thiard News@F4F

@newsen.bsky.social

5 months ago

New Quest AD-Detect Tests Offer High Accuracy in Alzheimer's Diagnosis A recent study has confirmed the accuracy of two Quest AD-Detect blood tests for diagnosing Alzheimer's disease, reducing the need for invasive procedures.

New Quest AD-Detect Tests Offer High Accuracy in Alzheimer's Diagnosis #United_States #Alzheimer's_Disease #Quest_Diagnostics #Secaucus #AD-Detect

Thiard News@F4F

@newsen.bsky.social

5 months ago

Quest Diagnostics Delivers Strong Third Quarter Financial Results and Raises 2025 Guidance Quest Diagnostics has reported strong financial results for the third quarter of 2025, including a revenue increase of 13.1% for the quarter and an upward revision of guidance for the overall year.

Quest Diagnostics Delivers Strong Third Quarter Financial Results and Raises 2025 Guidance #United_States #financial_results #Quest_Diagnostics #Secaucus #EPS

Thiard News@F4F

@newsen.bsky.social

6 months ago

Quest Diagnostics and Epic Announce Innovative Partnership to Elevate Lab Testing Experience Quest Diagnostics and Epic have formed a groundbreaking collaboration aimed at enhancing the laboratory testing experience, improving efficiency and patient satisfaction.

Quest Diagnostics and Epic Announce Innovative Partnership to Elevate Lab Testing Experience #United_States #healthcare_technology #Quest_Diagnostics #Secaucus #Epic

Thiard News@F4F

@newsen.bsky.social

6 months ago

Insights from Quest Diagnostics' CFO at the Upcoming Jefferies Healthcare Conference Quest Diagnostics will feature CFO Sam Samad at the Jefferies Healthcare Services Conference, discussing strategies and market trends in healthcare.

Insights from Quest Diagnostics' CFO at the Upcoming Jefferies Healthcare Conference #United_States #healthcare #Nashville #Quest_Diagnostics #Sam_Samad

Thiard News@F4F

@newsen.bsky.social

7 months ago

Rising Fentanyl Positivity in U.S. Workforce Raises Alarm: 2025 Report The 2025 Quest Diagnostics Drug Testing Index reveals a staggering increase in fentanyl positivity among U.S. workers, raising serious health concerns.

Rising Fentanyl Positivity in U.S. Workforce Raises Alarm: 2025 Report #USA #Quest_Diagnostics #Secaucus #Drug_Testing #fentanyl

Thiard News@F4F

@newsen.bsky.social

7 months ago

Corewell Health and Quest Diagnostics Collaborate for Enhanced Lab Services in Michigan Corewell Health and Quest Diagnostics are joining forces to enhance laboratory services in Michigan through a new joint venture. This partnership aims to streamline access to top-notch diagnostic solutions.

Corewell Health and Quest Diagnostics Collaborate for Enhanced Lab Services in Michigan #United_States #Southfield #Quest_Diagnostics #Diagnostic_Labs #Corewell_Health

Thiard News@F4F

@newsen.bsky.social

7 months ago

Quest Diagnostics to Discuss Strategies at Baird Global Healthcare Conference 2025 Quest Diagnostics will present its strategies and market insights at the Baird 2025 Global Healthcare Conference. Join the live session!

Quest Diagnostics to Discuss Strategies at Baird Global Healthcare Conference 2025 #United_States #New_York #healthcare #Market_Trends #Quest_Diagnostics

Thiard News@F4F

@newsen.bsky.social

7 months ago

Quest Diagnostics Announces Quarterly Cash Dividend for Shareholders Quest Diagnostics has declared a quarterly cash dividend of $0.80 per share, set to enrich shareholder value. The payment is scheduled for October 20, 2025.

Quest Diagnostics Announces Quarterly Cash Dividend for Shareholders #United_States #Cash_Dividend #diagnostics #Quest_Diagnostics #Secaucus

Thiard News@F4F

@newsen.bsky.social

8 months ago

Quest Diagnostics Expands Services Through Acquisition of Clinical Testing Assets Quest Diagnostics has successfully completed its acquisition of clinical testing assets from Fresenius Medical Care, enhancing its dialysis-related testing capabilities for clinics.

Quest Diagnostics Expands Services Through Acquisition of Clinical Testing Assets #United_States #Quest_Diagnostics #Secaucus #Fresenius_Medical_Care #Clinical_Testing

Thiard News@F4F

@newsen.bsky.social

8 months ago

Quest Diagnostics Reports Strong Q2 2025 Earnings and Raises Annual Guidance Significantly Quest Diagnostics has announced robust financial results for the second quarter of 2025, boosting its annual earnings guidance significantly as demand for services increases.

Quest Diagnostics Reports Strong Q2 2025 Earnings and Raises Annual Guidance Significantly #USA #financial_results #Quest_Diagnostics #Q2_2025 #Secaucus,_New_Jersey

Thiard News@F4F

@newsen.bsky.social

8 months ago

Quest Diagnostics Launches Oropouche Virus Diagnostic Testing amidst Emerging Health Concerns Quest Diagnostics has introduced a new test for the Oropouche virus, addressing an emerging health threat in the Americas. This innovative diagnostic tool aims to enhance public health response and preparedness.

Quest Diagnostics Launches Oropouche Virus Diagnostic Testing amidst Emerging Health Concerns #USA #Quest_Diagnostics #Secaucus #Oropouche_Virus #Diagnostics_Service

Thiard News@F4F

@newsen.bsky.social

9 months ago

Quest Diagnostics Launches FDA-Cleared Blood Test for Early Alzheimer's Detection Quest Diagnostics is set to offer an FDA-cleared blood test from Fujirebio for Alzheimer's disease. This innovative test aims to improve early detection and accessibility for patients showing cognitive impairment.

Quest Diagnostics Launches FDA-Cleared Blood Test for Early Alzheimer's Detection #United_States #Quest_Diagnostics #Secaucus #Alzheimer's_Test #Fujirebio

Thiard News@F4F

@newsen.bsky.social

9 months ago

Quest Diagnostics Unveils Comprehensive Corporate Responsibility Report for 2024 Quest Diagnostics has released its 2024 Corporate Responsibility Report, highlighting efforts in health access, community engagement, and sustainability.

Quest Diagnostics Unveils Comprehensive Corporate Responsibility Report for 2024 #United_States #Quest_Diagnostics #Secaucus #Corporate_Responsibility #Health_Initiatives

Thiard News@F4F

@newsen.bsky.social

10 months ago

Quest Diagnostics Innovates New Blood Test for Multi-Cancer Detection with MD Anderson Quest Diagnostics has announced a promising collaboration with MD Anderson to create a blood test focused on identifying multiple cancers early, enhancing patient screenings.

Quest Diagnostics Innovates New Blood Test for Multi-Cancer Detection with MD Anderson #USA #MD_Anderson #Quest_Diagnostics #Secaucus #multi-cancer_test

Thiard News@F4F

@newsen.bsky.social

10 months ago

Jim Davis to Present Quest Diagnostics' Strategies at William Blair Conference Jim Davis, CEO of Quest Diagnostics, will discuss the company's strategies and market trends at the upcoming William Blair Growth Stock Conference, showcasing its commitment to healthcare innovation.

Jim Davis to Present Quest Diagnostics' Strategies at William Blair Conference #United_States #Chicago #Quest_Diagnostics #Jim_Davis #William_Blair

Thiard News@F4F

@newsen.bsky.social

10 months ago

Quest Diagnostics Announces a $0.80 Quarterly Cash Dividend for Shareholders Quest Diagnostics has declared a quarterly cash dividend of $0.80 per share, set to benefit shareholders by enhancing financial returns in July 2025.

Quest Diagnostics Announces a $0.80 Quarterly Cash Dividend for Shareholders #United_States #Cash_Dividend #Quest_Diagnostics #Secaucus #NYSE_DGX